Emerging roles of the ribonucleotide reductase M2 in colorectal cancer and ultraviolet-induced DNA damage repair

被引:41
|
作者
Lu, Ai-Guo [1 ]
Feng, Hao [1 ]
Wang, Pu-Xiong-Zhi [1 ]
Han, Ding-Pei [2 ]
Chen, Xue-Hua [3 ]
Zheng, Min-Hua [1 ]
机构
[1] Shanghai Jiao Tong Univ, Shanghai Minimally Invas Surg Ctr, Ruijin Hosp, Sch Med, Shanghai 200025, Peoples R China
[2] Shanghai Jiao Tong Univ, Dept Surg, Ruijin Hosp, Sch Med, Shanghai 200011, Peoples R China
[3] Shanghai Jiao Tong Univ, Shanghai Inst Digest Surg, Ruijin Hosp, Sch Med, Shanghai 200011, Peoples R China
关键词
Ribonucleotide reductase M2; Colorectal cancers; Tissue microarray; Ultraviolet irradiation; Cancinogenesis; Metabolic genes; GENE-EXPRESSION; BREAST-CANCER; SUBUNIT; CELLS; M1; OVEREXPRESSION; HYDROXYUREA; RESISTANCE; COLON;
D O I
10.3748/wjg.v18.i34.4704
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
AIM: To investigate the roles of the ribonucleotide reductase M2 (RRM2) subunit in colorectal cancer (CRC) and ultraviolet (UV)-induced DNA damage repair. METHODS: Immunohistochemical staining of tissue microarray was performed to detect the expression of RRM2. Seven CRC cell lines were cultured and three human colon cancer cell lines, i.e., HCT116, 5W480 and 5W620, were used. Reverse transcription polymerase chain reaction and Western blotting were performed to determine the mRNA and protein expression levels of RRM2, respectively. Cell proliferation assay, cell cycle analysis were performed. Cell apoptosis was evaluated by double staining with fluorescein isothiocyanateconjugated Annexin V and propidium iodide (PI) using Annexin V/PI apoptosis kit. The motility and invasion of CRC cells were assessed by the Transwell chamber assay. Cells were irradiated with a 254 nm UV-C lamp to detect the UV sensitivity after RRM2 depletion. RESULTS: Immunohistochemical staining revealed elevated RRM2 levels in CRC tissues. RRM2 overexpression was positively correlated with invasion depth (P < 0.05), poorly differentiated type (P = 0.0051), and tumor node metastasis stage (P = 0.0015). The expression of RRM2 in HCT116 cells was downregulated after transfection, and HCT116 cell proliferation was obviously suppressed compared to control groups (P < 0.05). In the invasion test, the number of cells that passed through the chambers in the RRM2-siRNA group was 81 +/- 3, which was lower than that in the negative control (289 +/- 7) and blank control groups (301 +/- 7.2). These differences were statistically significant (P < 0.01). Our data suggest that RRM2 overexpression may be associated with CRC progression. RRM2 silencing by siRNA may inhibit the hyperplasia and invasiveness of CRC cells, suggesting that RRM2 may play an important role in the infiltration and metastasis of CRC, which is a potential therapeutic strategy in CRC. In addition, RRM2 depletion increased UV sensitivity. CONCLUSION: These findings suggest that RRM2 may be a facilitating factor in colorectal tumorigenesis and UV-induced DNA damage repair. (c) 2012 Baishideng. All rights reserved.
引用
收藏
页码:4704 / 4713
页数:10
相关论文
共 50 条
  • [41] Ribonucleotide reductase M2 subunit is a novel diagnostic marker and a potential therapeutic target in bladder cancer
    Morikawa, Teppei
    Maeda, Daichi
    Kume, Haruki
    Homma, Yukio
    Fukayama, Masashi
    HISTOPATHOLOGY, 2010, 57 (06) : 885 - 892
  • [42] The Role of Ribonucleotide Reductase M2 in Lung Cancer Progression and Chemotherapy Resistance: A Bioinformatics Analysis and Review
    Wang, Jin-Jie
    Zhou, Shui-Ying
    Zhao, Ming
    Tang, Hai-Long
    Shan, De-Shen
    Wang, Hao
    AMERICAN JOURNAL OF THERAPEUTICS, 2025, 32 (01) : e100 - e106
  • [43] A pan-cancer analysis of the oncogenic role of ribonucleotide reductase subunit M2 in human tumors
    Li, Yaqun
    Fu, Wenhuan
    Geng, Zikai
    Song, Yun
    Yang, Xionggang
    He, Tianye
    Wu, Jian
    Wang, Bin
    PEERJ, 2022, 10
  • [44] Repositioning of a cyclin-dependent kinase inhibitor GW8510 as a ribonucleotide reductase M2 inhibitor to treat human colorectal cancer
    Hsieh, Y-Y
    Chou, C-J
    Lo, H-L
    Yang, P-M
    CELL DEATH DISCOVERY, 2016, 2
  • [45] Repositioning of a cyclin-dependent kinase inhibitor GW8510 as a ribonucleotide reductase M2 inhibitor to treat human colorectal cancer
    Y-Y Hsieh
    C-J Chou
    H-L Lo
    P-M Yang
    Cell Death Discovery, 2
  • [46] The expression of ribonucleotide reductase subunit M2 is associated with nuclear localization of \#946;catenin and impact outcome of colorectal cancers
    Liu, Xiyong
    Lai, Lily
    Leora, Sofia
    He, Huiying
    Zhang, Kegiang
    Wang, Xiaochen
    Nelson, Rebecca
    Zhou, Bingsen
    Chu, Peiguo
    Yen, Yun
    CANCER RESEARCH, 2009, 69
  • [47] Ribonucleotide Reductase Small Subunit M2B Prognoses Better Survival in Colorectal Cancer
    Liu, Xiyong
    Lai, Lily
    Wang, Xiaochen
    Xue, Lijun
    Leora, Sofia
    Wu, Jun
    Hu, Shuya
    Zhang, Keqiang
    Kuo, Mei-Ling
    Zhou, Lun
    Zhang, Hang
    Wang, Yafan
    Wang, Yan
    Zhou, Bingsen
    Nelson, Rebecca A.
    Zheng, Shu
    Zhang, Suzhan
    Chu, Peiguo
    Yen, Yun
    CANCER RESEARCH, 2011, 71 (09) : 3202 - 3213
  • [48] Reduced Level of Ribonucleotide Reductase R2 Subunits Increases Dependence on Homologous Recombination Repair of Cisplatin-Induced DNA Damage
    Lin, Z. Ping
    Lee, Yashang
    Lin, Fang
    Belcourt, Michael F.
    Li, Peining
    Cory, Joseph G.
    Glazer, Peter M.
    Sartorelli, Alan C.
    MOLECULAR PHARMACOLOGY, 2011, 80 (06) : 1000 - 1012
  • [49] Ribonucleotide reductase subunits M2 and p53R2 are potential biomarkers for metastasis of colon cancer
    Liu, Xiyong
    Zhou, Bingsen
    Xue, Lijun
    Yen, Frank
    Chu, Peiguo
    Un, Frank
    Yen, Yui
    CLINICAL COLORECTAL CANCER, 2007, 6 (05) : 374 - 381
  • [50] Evidence for upregulated repair of oxidatively induced DNA damage in human colorectal cancer
    Kirkali, Guldal
    Keles, Didem
    Canda, Aras E.
    Terzi, Cem
    Reddy, Prasad T.
    Jaruga, Pawel
    Dizdaroglu, Miral
    Oktay, Gulgun
    DNA REPAIR, 2011, 10 (11) : 1114 - 1120